Aggressive smoking quit program after heart problems
Part of Heart & circulation clinical trials.
This trial tests whether a strong quit plan using varenicline (a quit pill) plus nicotine e-cigarettes, along with counseling, helps people stop smoking after a recent heart-related event. It’s aimed at people who want to quit and can safely stay involved for about a year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older and currently smoke at least some cigarettes most days (about a year or more).
- You recently had certain heart problems, such as a heart attack, unstable angina, or known heart/vascular disease.
- You’re in the hospital now or recently discharged, or you’re an outpatient with documented heart or related blood-vessel disease.
- You’re motivated to quit smoking and can sign consent in English or French.
- If you’re placed in the main treatment group, you can buy specific nicotine e-cigarettes (rechargeable, sealed pods, no tobacco/flavors, and low nicotine strength).
- You can likely return for follow-up visits for 52 weeks (about one year).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether switching from regular cigarettes to e-cigarettes helps smokers who are not interested in quitting. You would also be offered varenicline and regular check-ins to compare outcomes over time.
This study tests whether using two quit-smoking medicines together helps people stop both cigarettes and vaping. It may offer extra support to help you quit.
This study tests whether adding a gentle nerve stimulation device to nicotine replacement therapy (like patches or gum) can help people quit smoking more effectively. It may be a new option for those who have struggled to quit before.
This trial tests if varenicline, a stop-smoking medication, can help people ages 18 to 40 quit e-cigarettes while also using cannabis. It's designed for regular e-cigarette users who want to quit and who use cannabis at least 10 days per month.
This trial tests whether a quit program that combines counseling with medicines (nicotine replacement, varenicline, or bupropion) helps people stop or cut down smoking. It’s also delivered through telehealth, with repeated check-ins to see how well the plan works and whether it’s safe for you.
This trial tests whether varenicline, a medicine that reduces cravings, can help people quit using e-cigarettes that contain nicotine. You must be a daily nicotine vaper and live in Connecticut or South Carolina.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.